(IN BRIEF) Evonik is now offering customers cradle-to-gate Life Cycle Assessment (LCA) data for selected EUDRAGIT® functional polymers, using its TÜV-certified LCA methodology to support pharmaceutical companies with transparent environmental data for Scope 3 emissions reporting. The data is currently … Read the full press release
Posted in Business, Chemicals, Environment, Healthcare, Industrial, Pharma & Biotech, Science, Technology
Tagged 2030 sustainability targets, climate neutrality, coatings, cradle-to-gate assessment, Custom Solutions, Darmstadt, data-driven decisions, delayed release, Dr Jürgen Krauter, drug delivery, emissions reporting, energy use, environmental footprint, environmental transparency, ESG requirements, Essen, EUDRAGIT, EUDRAGIT L 100-55, EUDRAGIT L 30 D-55, EUDRAGIT® L 100-55 Shows 6 Percent Product Carbon Footprint Reduction, Evonik, Evonik Expands Sustainability Transparency for EUDRAGIT® Functional Polymers, Evonik Health Care, Evonik Industries AG, Evonik Offers Cradle-to-Gate LCA Data for Pharmaceutical Excipients, Functional Polymers, Germany, healthcare sustainability, hot melt extrusion, immediate release, Janusz Berger, LCA data, life cycle assessment, Muhammad Irfan, Next Generation Solutions, Oral Drug Delivery Solutions, PCF, pharmaceutical excipients, pharmaceutical processes, pharmaceutical products, pharmaceutical value chain, polymethacrylates, poorly soluble drug substances, process efficiency, product carbon footprint, renewable electricity, Scope 1 emissions, scope 2 emissions, Scope 3 emissions, solubility enhancement, spray drying, spray drying system, surface treatments, sustainability strategy, sustained release, Thilo Krapfl, TRANSPORT, TÜV-certified LCA methodology
(IN BRIEF) Evonik is selling selected production assets for pharmaceutical ingredients at its Hanau site in Germany to the ProChem Group, with the transaction expected to close on 19 June 2026. The divestment supports Evonik Health Care’s strategy of streamlining … Read the full press release
Posted in Business, Chemicals, European Union, France, Germany, Healthcare, Industrial, Pharma & Biotech, Science, Technology
Tagged active pharmaceutical ingredients, advanced pharmaceutical lipids, amino acids, analytical testing, APIs, asset streamlining, CDMO services, cell-culture ingredients, contract manufacturing, cosmetics ingredients, distillation, Dr Jürgen Krauter, drug delivery technologies, drying, Essen, Evonik, Evonik Advances Health Care Growth Strategy Through Hanau Production Asset Transfer, Evonik Health Care, Evonik Sells Hanau Pharmaceutical Ingredient Production Assets to ProChem Group, Evonik Streamlines Health Care Footprint with Sale of Selected Hanau Assets to ProChem, extraction, food additives, France, gene delivery, Gerhard Jakobi, Germany, GMP facility, GMP-compliant production, grinding, Guido Skudlarek, Ham, Hanau, healthcare portfolio, injectable drug delivery, Intermediates, Janusz Berger, Jochen Pohl, Jörg Blumhoff, Kerstin Oberhaus, keto acids, mixing, mRNA delivery, oral drug delivery, packaging, pharmaceutical customers, pharmaceutical ingredients, pharmaceutical lipids, pharmaceutical-grade products, precision biosolutions, ProChem Acquires Evonik GMP Production Facilities for Pharmaceutical Ingredients in Hanau, ProChem GmbH, ProChem Group, ProChem InnoTec GmbH, production assets, regulatory-compliant solutions, REXIM, RNA therapeutics, sieving, specialty chemicals, synthesis, Thomas Hermann, Wuming
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?